Ignite Creation Date:
2025-12-24 @ 4:18 PM
Ignite Modification Date:
2026-02-05 @ 2:41 PM
Study NCT ID:
NCT03487666
Status:
COMPLETED
Last Update Posted:
2024-12-03
First Post:
2018-03-20
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
OXEL: Immune Checkpoint or Capecitabine or Combination Therapy as Adjuvant Therapy for TNBC With Residual Disease
Sponsor:
Georgetown University
Organization: